Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 2429Neoplasms 1840Carcinoma, Non-Small-Cell Lung 1615Prostatic Neoplasms 1309Colorectal Neoplasms 1147Lung Neoplasms 991Neoplasm Metastasis 836Multiple Myeloma 801Leukemia, Myeloid, Acute 777Ovarian Neoplasms 682Pancreatic Neoplasms 667Melanoma 667Squamous Cell Carcinoma of Head and Neck 592Recurrence 568Carcinoma, Hepatocellular 568Brain Neoplasms 529Glioblastoma 519Stomach Neoplasms 504Head and Neck Neoplasms 503Triple Negative Breast Neoplasms 472Lymphoma 462Uterine Cervical Neoplasms 454Carcinoma, Renal Cell 429Precursor Cell Lymphoblastic Leukemia-Lymphoma 419Lymphoma, Non-Hodgkin 392Endometrial Neoplasms 385Sarcoma 370Lymphoma, Follicular 358Urinary Bladder Neoplasms 356Lymphoma, Large B-Cell, Diffuse 355

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hereditary Cancer × 1 year × Clear all
NCT06073626 2025-10-28

Addressing Genomic Disparities in Cancer Survivors

Rutgers, The State University of New Jersey

Phase NA Recruiting
428 enrolled

Hereditary Cancer

NCT06284330 2025-09-05

CHARGE

University of Texas Southwestern Medical Center

Phase NA Completed
108 enrolled

Hereditary Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡